Abrilumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Abrilumab
Monoclonal antibody
Type ?
Source Human
Target integrin alpha-4 beta-7
Clinical data
Synonyms AMG 181
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
Formula C6362H9806N1686O2014S52
Molar mass 143.8 kg/mol

Abrilumab (AMG 181) (INN[1]) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.[2]

This drug was developed by MedImmune.

References[edit]

External links[edit]